Work

Coverage and Prior Authorization Policies for Semaglutide and Tirzepatide in Medicare Part D Plans

Year: 2025

Type: article

Abstract: This cross-sectional study examines trends in coverage of glucagon-like peptide-1 receptor agonists, semaglutide and tirzepatide, and prior authorization requirements among Medicare Part D beneficiaries.

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2025.29842

Authors: Xiaoyu Liu, Chuan Angel Lu, Ya-Chen Tina Shih, Changchuan Jiang

Institutions: University of California, Los Angeles, The University of Texas Southwestern Medical Center, UCLA Jonsson Comprehensive Cancer Center

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: Sanofi, National Cancer Institute

Award: G2952438131

OpenAlex ID: W4413816351

FWCI: 5.98

Cites: 3

Cited by: 10

Related to: 10